Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,927,651
+$7,626,376 QoQ
Shares Held
48,469
+109.1% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
2.62%
of 13F equity value
Holder Rank
#84
of 303 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. ASND ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
This page
|
48,469 | $12,927,651 |
All Filings in ASND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,927,651 | 48,469 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,301,275 | 23,177 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,008,463 | 28,177 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,595,919 | 33,177 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,544,050 | 72,677 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,530,832 | 80,398 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,228,882 | 103,355 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,373,995 | 89,572 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,042,961 | 80,972 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,978,992 | 92,472 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $15,551,298 | 123,472 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,754,891 | 136,212 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,067,671 | 135,212 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,497,430 | 135,212 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,902,791 | 130,212 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,013,621 | 135,712 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,941,147 | 139,212 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,592,624 | 30,612 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,479,830 | 11,000 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $938,872 | 7,137 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,994,784 | 23,237 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,875,466 | 23,237 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,511,853 | 29,237 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,105,652 | 14,237 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,799,123 | 33,737 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||